V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210035758 | 210019275 | 1.83 | 106.499 | Curative (C) | null | 2018-12-26 | UKALL14- Cons Cycle 2 | N | N | 210014851 | UKALL2014 |
| 210035759 | 210008188 | 1.7 | 74.4 | Curative (C) | 2018-05-04 | 2018-05-04 | UKALL14- Cons Cycle 2 | Y | N | 210014860 | UKALL2014 |
| 210035760 | 210033170 | 1.83 | 83.8 | Curative (C) | null | 2014-10-15 | UKALL14- Intens/CNS Proph | Y | N | 210014878 | UKALL2014 |
| 210035761 | 210008199 | 0 | 84.9 | Curative (C) | 2018-02-05 | 2018-03-14 | UKALL14- Maintenance | 01 | N | 210014880 | UKALL2014 |
| 210035762 | 210019281 | null | 90 | Curative (C) | 2016-06-06 | 2016-10-31 | UKALL14- Cons Cycle 3 | Y | N | 210014892 | UKALL2014 |
| 210035763 | 210008206 | 1.66 | 99.6 | Curative (C) | 2014-02-17 | 2014-11-09 | UKALL14- FMC (2 day) Conditioning | Y | N | 210014900 | UKALL2014 |
| 210035764 | 210008209 | 1.56 | 69.6 | Curative (C) | null | 2015-09-21 | UKALL14- Maintenance | Y | N | 210014907 | UKALL2014 |
| 210035765 | 210008215 | 1.88 | 75 | Not known (9) | 2017-09-20 | 2018-01-12 | UKALL14- Maintenance | Y | N | 210014930 | UKALL2014 |
| 210035766 | 210019288 | 1.85 | 103 | Curative (C) | null | 2017-06-22 | UKALL14- Ph 2 Induction + Imatinib | N | N | 210014933 | UKALL2014 |
| 210035767 | 210019291 | 1.71 | 75 | Curative (C) | 2015-06-26 | 2015-06-26 | UKALL14- Maintenance | 02 | N | 210014955 | UKALL2014 |
| 210035768 | 210008230 | 1.76 | 84.4 | Curative (C) | 2016-06-28 | 2016-11-23 | UKALL14- Ph 2 Induction | Y | null | 210014963 | UKALL2014 |
| 210035769 | 210008245 | 1.83 | 73 | Curative (C) | 2016-05-17 | 2018-07-16 | UKALL14- Maintenance | 1 | N | 210015020 | UKALL2014 |
| 210035770 | 210008254 | 1.86 | 87.3 | Curative (C) | 2013-10-04 | 2013-12-15 | UKALL14- Intens/CNS Proph +Imatinib | 2 | N | 210015041 | UKALL2014 |
| 210035771 | 210008259 | 1.68 | 53 | Curative (C) | 2017-04-11 | 2017-04-12 | UKALL 14 TRIAL | Y | null | 210015062 | UKALL2014 |
| 210035772 | 210008264 | 1.55 | 74.4 | Palliative (P) | null | 2014-06-09 | UKALL14- Maintenance | N | N | 210015067 | UKALL2014 |
| 210035773 | 210008268 | 1.7 | 102 | Adjuvant (A) | 2014-05-01 | 2014-05-01 | UKALL14- Intens/CNS Proph | Y | N | 210015070 | UKALL2014 |
| 210035774 | 210008275 | null | 84.9 | Curative (C) | 2014-10-18 | 2014-10-18 | UKALL14- FMC (1 day) Conditioning | 02 | N | 210015090 | UKALL2014 |
| 210035775 | 210026407 | null | 93.8 | null | 2013-05-24 | 2013-08-18 | UKALL14- Cons Cycle 3 | Y | Y | 210015114 | UKALL2014 |
| 210035776 | 210008289 | 1.84 | 71.8 | Curative (C) | null | 2015-08-17 | UKALL14- Cons Cycle 1 | Y | N | 210015133 | UKALL2014 |
| 210035777 | 210008294 | 1.87 | 118.2 | Curative (C) | 2014-04-15 | 2014-09-22 | UKALL14- Cons Cycle 1 + Imatinib | Y | N | 210015141 | UKALL2014 |
| 210035778 | 210008300 | 1.69 | 59 | Disease modification (D) | 2019-01-20 | 2019-02-03 | UKALL14- Cons Cycle 1 | N | N | 210015173 | UKALL2014 |
| 210035779 | 210008306 | null | 70.1 | Curative (C) | 2015-06-12 | 2015-06-21 | UKALL14- Maintenance + Imatinib | Y | null | 210015192 | UKALL2014 |
| 210035780 | 210008313 | 1.83 | 127.5 | Curative (C) | 2015-05-15 | 2015-11-02 | UKALL14- FMC (1 day) Conditioning | N | N | 210015202 | UKALL2014 |
| 210035781 | 210008317 | 1.66 | 54.8 | Curative (C) | 2016-02-06 | 2016-02-19 | UKALL14- Maintenance | Y | N | 210015206 | UKALL2014 |
| 210035782 | 210008323 | 1.58 | 61 | Curative (C) | 2016-06-21 | 2016-06-25 | UKALL14- Intens/CNS Proph | Y | null | 210015216 | UKALL2014 |
| 210035783 | 210008331 | 1.87 | 72 | Curative (C) | 2015-01-31 | 2015-02-08 | UKALL14- Maintenance | 02 | N | 210015220 | UKALL2014 |
| 210035784 | 210008337 | 1.75 | 71.7 | Curative (C) | 2015-05-29 | 2015-05-29 | UKALL14- Cons Cycle 1 | 2 | N | 210015224 | UKALL2014 |
| 210035785 | 210008355 | 1.74 | 19.8 | Curative (C) | null | 2018-05-18 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | Y | null | 210015258 | NOT MATCHED |
| 210035786 | 210008360 | null | 16.8 | Curative (C) | 2015-02-25 | 2015-10-15 | WT SIOP 2002 01 post op Vinc alone | Y | N | 210015268 | NOT MATCHED |
| 210035787 | 210008367 | 1.49 | 16.4 | Curative (C) | 2017-12-29 | 2018-01-15 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PEGASPARAGINASE | Y | N | 210015285 | NOT MATCHED |
| 210035788 | 210008373 | null | 12 | Palliative (P) | 2016-05-03 | 2016-05-03 | CNS Epen2007 09 Baby Brn vinc+Mtx | N | Y | 210015306 | NOT MATCHED |
| 210035789 | 210008382 | null | 54.3 | Curative (C) | 2016-11-10 | 2016-12-17 | TEMOZOLOMIDE + DEPATUXIZUMAB | Y | N | 210015310 | NOT MATCHED |
| 210035791 | 210008396 | 1.08 | 43.3 | Curative (C) | 2015-03-27 | 2015-05-24 | CNS Epen2007 09 Baby Brn vinc+cyclo | N | N | 210015323 | NOT MATCHED |
| 210035793 | 210008424 | 0 | 13 | Curative (C) | 2016-08-02 | 2016-08-09 | CNS Medullo HR Cis/Vinc/Cyclo + PBSCR | N | N | 210015414 | NOT MATCHED |
| 210035794 | 210008434 | null | 8.6 | Curative (C) | 2015-03-21 | 2015-04-18 | CNS ATRT Carboplatin/Thiotepa + GCSF | Y | N | 210015424 | NOT MATCHED |
| 210035795 | 210008448 | null | 49.3 | Curative (C) | 2016-04-25 | 2016-04-26 | CNS High Grade Glioma PCV | 1 | N | 210015447 | NOT MATCHED |
| 210035796 | 210008450 | null | 11.3 | Curative (C) | 2017-03-04 | 2017-04-08 | NB Rel CCLG guidelines Cyclo-Topotecan | N | N | 210015451 | NOT MATCHED |
| 210035797 | 210008455 | null | 13.9 | Adjuvant (A) | 2013-06-26 | 2014-02-04 | CNS Infant MBL Car/Etop | Y | N | 210015455 | NOT MATCHED |
| 210035798 | 210008460 | 1.38 | 86.2 | Curative (C) | 2013-08-15 | 2013-09-25 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | N | null | 210015471 | NOT MATCHED |
| 210035799 | 210008465 | null | 9.5 | Curative (C) | 2016-02-16 | 2016-05-19 | ALL Interfant 06 MARMA: Ph II PAsp | N | N | 210015472 | NOT MATCHED |
| 210035800 | 210019371 | null | 70.1 | Curative (C) | 2016-09-02 | 2016-11-12 | CNS Ependymoma II Cisplatin | N | N | 210015487 | NOT MATCHED |
| 210035801 | 210008482 | null | 62.6 | Curative (C) | 2016-06-02 | 2016-06-02 | CNS Epen2007 09 Baby Brn cisplatin | N | null | 210015510 | NOT MATCHED |
| 210035802 | 210008494 | null | 9.3 | Disease modification (D) | 2018-10-19 | 2019-08-13 | WT SIOP 2002 01 post op Vinc alone | N | N | 210015534 | NOT MATCHED |
| 210035803 | 210008497 | null | 23.3 | Curative (C) | 2018-03-31 | 2018-04-14 | PNET 4 HIT-SIOP Chemo + RT | N | Y | 210015535 | NOT MATCHED |
| 210035804 | 210008505 | 1.85 | null | Curative (C) | 2018-02-16 | 2018-04-03 | CNS LGG Temozolomide | 1 | null | 210015563 | NOT MATCHED |
| 210035805 | 210008516 | null | 14.2 | Curative (C) | 2016-12-22 | 2017-05-10 | AML Interim Guidelines | N | N | 210015606 | NOT MATCHED |
| 210035806 | 210008520 | null | 65.95 | Curative (C) | 2013-12-26 | 2014-02-09 | BMT | N | N | 210015612 | NOT MATCHED |
| 210035807 | 210008524 | null | 16.4 | Disease modification (D) | 2017-10-04 | 2017-12-27 | CYTARABINE + MERCAPTOPURINE + METHOTREXATE + PEGASPARAGINASE + VINCRISTINE | 01 | N | 210015620 | NOT MATCHED |
| 210035808 | 210030576 | 1.6 | 10.9 | Curative (C) | 2016-07-16 | 2016-07-16 | null | Y | N | 210015630 | NOT MATCHED |
| 210035809 | 210008532 | 0 | 10 | Palliative (P) | 2016-02-22 | 2017-10-30 | CNS Medbl Std Risk weekly vinc+ xrt | 1 | N | 210015631 | NOT MATCHED |